- The type of dizziness/vertigo: rotatory vertigo resembles the sensation The trial revealed that monotherapy with a glucocorticoid-methylprednisolone
OBJECTIVE: To assess the effect of intratympanic methylprednisolone (ITMP) in posterior canal benign paroxysmal positional vertigo (BPPV)
distension; abdominal pain; diarrhoea; dyspepsia; nausea; vomiting methylPREDNISolone sodium succinate may cause dizziness, vertigo
The average number of vertigo attacks decreased by 90% in the methylprednisolone group (from 16.4 attacks in the six months before treatment to
Vertigo was controlled in 70% of the patients in the gentamicin group and 50% in methylprednisolone group (0.085). The reduction of PTA was
Hypertension, hyperglycemia, vertigo, headache, nausea, hiccups, and peptic ulcer. Class. Glucocorticoids steroid. Mechanism of. Action. Methylprednisolone is
methylprednisolone in the management of SSNHL. methylprednisolone for three days, were Vertigo/tinnitus/ Co-morbidity Vertigo present Vertigo
The patients in the experimental group must be treated with methylprednisolone. The patients in the control group can receive any treatments, but not the methylprednisolone. 2.3.4 Type of outcome measurements. The primary outcome is vertigo, as measured by vertigo-related handicap and related scales.
Results: 50% patients had recovery with intravenous Methylprednisolone and 50% had no recovery. associated symptoms like tinnitus, vertigo
Comments